drugset / Trial / NCT02524119
LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
Phase 2
Terminated
5 enrolled
University of Texas Southwestern Medical Center
Novartis Pharmaceuticals · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is determine whether the combination therapy with LEE011 and chemoembolization in patients with locally advanced Hepatocellular Carcinoma not amenable to curative therapies will provide greater efficacy than chemoembolization alone with a tolerable safety profile.
Timeline
- Start
- 2016-04
- Primary completion
- 2020-09
- Completion
- 2020-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribociclib | Small molecule | 600 mg | Oral |